0001104659-23-040292.txt : 20230331
0001104659-23-040292.hdr.sgml : 20230331
20230331171038
ACCESSION NUMBER: 0001104659-23-040292
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230330
FILED AS OF DATE: 20230331
DATE AS OF CHANGE: 20230331
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mehra Raj
CENTRAL INDEX KEY: 0001757892
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22245
FILM NUMBER: 23789072
MAIL ADDRESS:
STREET 1: C/O SEELOS THERAPEUTICS, INC.
STREET 2: 300 PARK AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEELOS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001017491
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870449967
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 PARK AVENUE
STREET 2: 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (646) 293-2100
MAIL ADDRESS:
STREET 1: 300 PARK AVENUE
STREET 2: 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: APRICUS BIOSCIENCES, INC.
DATE OF NAME CHANGE: 20100914
FORMER COMPANY:
FORMER CONFORMED NAME: NEXMED INC
DATE OF NAME CHANGE: 19970311
4
1
tm2311208-2_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-03-30
0
0001017491
SEELOS THERAPEUTICS, INC.
SEEL
0001757892
Mehra Raj
C/O SEELOS THERAPEUTICS, INC.
300 PARK AVENUE, 2ND FLOOR
NEW YORK
NY
10022
1
1
0
0
See Remarks
0
Stock Option (right to buy)
0.69
2023-03-30
4
A
0
1682300
0.00
A
2033-03-30
Common Stock
1682300
1682300
D
Stock Option (right to buy)
0.69
2023-03-30
4
A
0
200000
0.00
A
2023-03-30
2033-03-30
Common Stock
200000
200000
D
1/4th of the shares subject to the option shall vest on March 30, 2024, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through such vesting date.
The Reporting Person voluntarily elected to be paid 36% of his 2022 annual cash bonus in the form of an option to purchase shares of common stock of the Issuer.
President, Chief Executive Officer and Chairman of the Board of Directors
/s/ Raj Mehra
2023-03-31